Ozone therapy, a supplement for patients with fibromyalgia

Abstract

Fibromyalgia is a disease of unknown ca use whose main sym ptom is chronic
widesprea d musculos keletal pain accompanied by s ymptoms th at disrupt daily
activities of patients. In this study the impact of ozone therapy in improving patients'
pai n and daily ac tivities to give them a bet ter quality of life was assessed. Clinical
experience is described us i ng ozone t herapy in 30 wo me n aged 30 -65 years
diagnosed with Fibromyalgia, Visual Analogue Scale (VAS) 6-9, with a time of disease
progression between 1-10 years. Patients were treated with O2-O3 intramuscular with
10 sessions 2 times a week at doses o f 15 mg / mL, to gether were administered
systemically 10 sessions 2 times a week alternating rectal insufflation and intravenous
admi nistration of s aline 0.9% ozonated. The outcome of patients was continued by
monitoring clinical symptoms and evaluation of the Visual Analogue Scale.
The results showed an improvement in pain with 33% VAS 3-4 in the second week,
improved sleep disorder in 46.6%, mood and daily activities by 40% and appreciated
a decrease in the amount of drugs consumed by 30% of patients.
The ozone therapy can be considered as an interesting as adjuva nt ther apy in the
symptoms of fibromyalgia.